Madelung’s disease is characterized by massive deposits of fatty tumors (lipoma) located symmetrically around the neck, and on the shoulders, upper arms and upper trunk. These abnormal fat deposits may grow rapidly over the course of months or more slowly over a period of years. The rest of the body may be lean in contrast to the affected parts. The fatty deposits do not indicate malignancy and, while disfiguring, may not impair functioning.
Peripheral neuropathy, or impaired function of the nerves in the arms and legs, often accompanies Madelung’s disease, especially as the affected person grows older. However, these neurological deficits may be difficult to distinguish from the long-term effects of alcoholism when overuse of alcohol is a factor.
Sometimes, there are metabolic abnormalities and other diseases associated with Madelung’s disease. These may include diabetes mellitus, hypertension, and liver disease.
The exact cause of Madelung’s disease is not known. The body’s inability to properly metabolize fat indicates that it may be an endocrine disorder. Some scientists believe a predisposition to the disorder may be inherited and there have been some reports of cases that appear to be familial. However, the mode of transmission in those cases has not been determined.
Madelung’s disease most frequently affects middle-aged males. The condition is most common in those who abuse alcohol. However, this disease is also found in women and persons who do not consume alcohol. For reasons that are unclear, the disorder appears to be more prevalent in Europe than in the United States.
The diagnosis of Madelung’s disease may involve ultrasound images, CAT scans, or magnetic resonance imaging.
Treatment consists of surgical removal of the fatty deposits from the areas around the head, neck, shoulders and trunk. Liposuction has been used successfully to remove single fatty tumors.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government website.
For information about clinical trials being conducted at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Foster DW, The lipodystrophies and other rare disorders of adipose tissue. In: Fauci AS et al., eds. Harrison’s Principles of Internal Medicine. New York, NY. McGraw-Hill Companies, Inc; 1998;2212.
Lee HW, Kim TH, Cho JW, et al. Multiple symmetric lipomatosis: Korean experience. Dermatol Surg. 2003;29:235-40.
Cossarizza A, Mussini C, Vigano A. Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays. 2001;23:1070-80.
Kakuda TN. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000;22:685-708.
Gonzalez-Garcia R, Rodriguez-Campos FJ, Sastre-Perez J, et al. Benign Symmetric Lipomatosis (Madelung’s Disease): Case reports and Current Management. Aesthetic Plast Surg. 2004 May 28[Epub ahead of print]
Verhelle NA, Nizet JL, Van den Hof B, et al. Liposuction in benign symmetric lipomatosis: sense or senseless? Aesthetic Plast Surg. 2003;27:319-21.
Busetto L, Strater D, Enzi G, et al. Differential clinical expression of multiple symmetric lipomatosis in men and women. Int J Obes Relat Metab Disord. 2003;27:1419-22.
Morelli F, De Benedetto A, Toto P, et al. Alcoholism as a trigger of multiple symmetric lipomatosis? J Eur Acad Dermatol Venereol. 2003;17:367-69.
Enzi G, Busetto L, Ceschin E, et al. Multiple symmetric lipomatosis: clinical aspects and outcomes in a long-term longitudinal study. Int J Obes Relat Metab Disord. 2002;26:253-61.
Ujpal M, Nemeth ZS, Reichwein A, et al. Long-term results following surgical treatment of benign symmetric lipomatosis (BSL). Int J Oral Maxillofac Surg. 2001;30:479-83.
FROM THE INTERNET
McKusick VA, ed. Online Mendelian Inheritance In Man (OMIM). The Johns Hopkins University. Lipomatosis, Familial Benign Cervical. Entry Number; 151800: Last Edit Date; 7/7/1997.
Madelungs Disease: Inherited from an Ancient Mediterranean Population. 1999.
The information in NORD’s Rare Disease Database is for educational purposes only and is not intended to replace the advice of a physician or other qualified medical professional.
The content of the website and databases of the National Organization for Rare Disorders (NORD) is copyrighted and may not be reproduced, copied, downloaded or disseminated, in any way, for any commercial or public purpose, without prior written authorization and approval from NORD. Individuals may print one hard copy of an individual disease for personal use, provided that content is unmodified and includes NORD’s copyright.
National Organization for Rare Disorders (NORD)
55 Kenosia Ave., Danbury CT 06810 • (203)744-0100